Merck KGaA may cut up to 4,500 jobs if its $17.4 billion hostile bid for fellow German drugmaker Schering AG succeeds, according to the Financial Times, which cites persons close to the situation.
Insider believes this to be at the low end of estimated "synergies".
No comments:
Post a Comment